Nexortest Technologies | Your Gateway to Global Market Entry

MOH Medical Device Registration and Authorized Representative Oman

Enter Oman a fast growing Gulf healthcare market backed by Vision 2040 hospital investment and rising medtech demand. NexorTest delivers end-to-end MOH DGPA&DC market access: Class A-D listing and registration under Decree 113/2020, CSDT dossier preparation, the CE & FDA reliance pathway, Omani Authorized Representative services and Apostille legalization all under one expert roof.

Free Oman Assessment

Get a personalised Oman market-entry roadmap

Oman Classification

Four Risk-Based Device Classes Under the MOH DGPA&DC

Oman applies the Oman follows a GHTF/IMDRF aligned risk based classification framework and may consider classifications assigned by recognized regulatory jurisdictions. Your class determines the depth of the CSDT dossier and the conformity evidence the Medical Device Control Department requires.

Class A (Low Risk)
Class A Devices

Non-invasive devices, surgical instruments, hospital beds, examination gloves and patient scales. Mapped from EU Class I and low risk FDA categories.

Does Class A still need an AR?Yes, even the lowest risk devices must be listed through an Omani Authorized Representative before they can be imported or placed on the market.
Class B (Low Moderate)
Class B Devices

Short term invasive and low to moderate risk devices such as surgical masks, suction equipment and hypodermic needles. Maps to EU Class IIa.

Does Class B need clinical data?Generally the CE or FDA file plus a Declaration of Conformity and ISO 13485 evidence suffice; DGPA&DC relies on the reference-market approval rather than new studies.
Class C (Moderate High)
Class C Devices

Moderate to high risk devices such as infusion pumps, ventilators, X ray and imaging equipment and contact lenses. Maps to EU Class IIb and parts of Class III.

What extra evidence does Class C need?An essential-principles conformity checklist, design verification and validation summaries and a post-market surveillance plan within the CSDT dossier.
Class D (High Risk)
Class D Devices

High risk Class III, Class IV and active implantable devices stents, heart valves, pacemakers and implantable defibrillators. The most rigorous review.

What documents do Class D devices need?A complete CSDT with full conformity evidence, clinical data, a risk management file (ISO 14971) and a robust post-market surveillance and vigilance plan.
Registration Pathways

Routes to Oman Market Access

Oman is transitioning from notification based listing to full risk based registration. NexorTest selects and manages the optimal pathway so you enter the market fast and stay compliant as the rules evolve.

Notification / Listing Pathway

The current mandatory step for market entry. Every device must be entered in the Medical Device Control Department database via the MOH eServices portal before it can be imported or sold. Leveraging an existing CE marking or US FDA clearance streamlines the file and gets you to market in roughly 3-4 months.

Registration Pathway

The fuller risk based market authorization being rolled out under Decree 113/2020 and the 2025 manufacturer-registration guidance. Requires a CSDT dossier with essential principles conformity, design verification and validation, and a Free Sale Certificate or Certificate of Foreign Government for US products.

Local Authorized Representative

Every foreign manufacturer must operate through an Omani Authorized Representative holding a Commercial Registration with approved medical device wholesale activity. NexorTest holds your authorization as an independent AR so you retain full control of your registrations.

Our Oman Services

End-to-End Oman Regulatory Consulting

From regulatory strategy and Authorized Representative appointment through CSDT documentation, MOH eServices submission and post-market compliance a complete one stop solution for the Omani market.

Authorized Representative

Independent Omani AR services, including Commercial Registration with medical device wholesale activity, manufacturer authorization letters and acting as your legal liaison with DGPA&DC.

Classification & Strategy

Accurate Class A/B/C/D determination mapped from your CE or FDA classification, with a listing first then registration roadmap and timeline forecast for Oman.

CSDT Documentation

Preparation and review of the Common Submission Dossier Template device description, essential principles, design verification and validation, labeling and the full registration file.

Listing & Notification

Compilation and submission of the official MOH listing Excel sheet to the Medical Device Control Department database for immediate, compliant market entry.

MOH eServices Submission

End-to-end management of the MOH eServices portal account setup, dossier upload, fee payment and application tracking through to authorization.

Apostille Legalization

Oman is an Apostille country we manage Apostille legalization of your CE, FDA, ISO 13485 and Free Sale certificates, plus certified Arabic/English translations.

Import License Support

Coordination of import licenses and clearance so your Authorized Representative can bring devices into Oman once listing or registration is granted.

IVD & SaMD Registration

Specialized support for In Vitro Diagnostics and Software as a Medical Device, covering performance evidence, software lifecycle and digital health documentation.

Post-Market Surveillance

Adverse event and field safety reporting, deficiency notice responses, change management and timely 5 year authorization renewals through your AR.

Why NexorTest

Why Manufacturers Choose Us for Oman

We hold your Oman authorization as Authorized Representative while leveraging your CE marking or FDA clearance to streamline listing and registration building registration grade CSDT dossiers that future proof your access as Decree 113/2020 is enforced.

Local AR + Global Strategy

A single partner that holds your Oman authorization as Authorized Representative while coordinating CE, US FDA, Saudi SFDA and wider GCC approvals across 50+ markets.

Reliance Pathway Specialists

We leverage your existing CE marking or FDA clearance to streamline Oman listing and registration, managing the Free Sale Certificate route when neither is available.

Transition Ready Filings

We list you for fast market entry today and build a registration grade CSDT so your Oman access is future proofed as Decree 113/2020 registration is enforced.

Transparent Fixed Fee Packages

Clear project based pricing from classification to authorization no surprise hourly charges, built for manufacturers, importers and start ups.

First Submission Acceptance
0 %
Countries Served
0 +
Faster Than Industry Average
0 %
Our Process

Six Steps to Your Oman Market Authorization

A proven, structured approach that maps your CE or FDA evidence to the Oman framework and gets you to market fast while future-proofing for full registration.

1
Appoint Authorized Representative

We act as your Omani AR with a Commercial Registration covering medical device wholesale activity, ready to submit to MOH DGPA&DC on your behalf.

2
Classification & Reliance Strategy

We confirm your Class A/B/C/D status from your CE or FDA file and define the listing first then registration strategy for Oman.

3
Dossier & Apostille

We assemble the CSDT, CE/FDA certificate, Declaration of Conformity, ISO 13485, Free Sale Certificate and labeling, with Apostille legalization.

4
MOH eServices Submission

We submit the listing Excel sheet and registration dossier through the MOH eServices portal and pay applicable fees.

5
Review & Query Management

We manage the DGPA&DC technical review, respond to deficiency notices and provide any samples or evidence requested.

6
Authorization & Post-Market

You receive your market authorization; we secure import licenses, set up vigilance reporting and manage renewals before the 5 year expiry.

Required Documentation

Oman MOH Registration Document Checklist

The MOH DGPA&DC requires a complete, legalized dossier. Oman is one of the few MENA Apostille countries, so most certificates need only Apostille rather than full consular legalization.

DocumentDescription & Guidance
CE Certificate or FDA Clearance RelianceCE certificate (EU MDR/MDD) or US FDA clearance (510(k), De Novo or PMA) the primary evidence of approval from a recognized reference market that underpins Oman reliance.
Free Sale Certificate / CFGIssued by the competent authority in the country of origin. For US manufactured products, a Certificate of Foreign Government (CFG) or CDNE is accepted, Apostille legalized.
Declaration of ConformityManufacturer's signed declaration confirming the device meets the essential principles and the requirements of the applicable EU directive or regulation.
ISO 13485 CertificateValid quality management system certificate covering the manufacturing site, current and issued by an accredited certification body.
CSDT Dossier Class B/C/DCommon Submission Dossier Template covering device description, essential principles, design verification and validation, labeling and post-market surveillance plan.
AR Authorization & CRManufacturer authorization letter appointing the Omani Authorized Representative, plus the AR's Commercial Registration showing approved medical device wholesale activity.
Labeling & IFUDevice labeling and Instructions for Use including the device identification number, manufacturer details and AR contact details; certified Arabic/English where required.
Risk Management File Class C/DISO 14971 risk-management documentation and clinical evidence for higher-risk devices, demonstrating benefit-risk acceptability.
Industries We Serve

Oman Registration Across All Device Sectors

Our regulatory team supports manufacturers across the full spectrum of medical technology and IVD categories entering Oman and the wider GCC.

FAQ's

Frequently Asked Questions for Medical Device Registration Oman

The Ministry of Health (MOH) regulates medical devices in Oman through the Directorate General of Pharmaceutical Affairs and Drug Control (DGPA&DC) and its Medical Device Control Department. The framework is enforced under Ministerial Decree 113/2020. Every device must be listed and increasingly registered before it can be imported, placed on the market or put into service in Oman.

Yes, Foreign manufacturers without a legal entity in Oman must appoint a local Omani Authorized Representative holding a Commercial Registration with approved medical device wholesale activity. The AR submits the listing and registration files, holds the authorization and is the DGPA&DC’s legal point of contact. NexorTest provides independent Authorized Representative services so you keep control of your registrations.

Oman uses the GHTF/IMDRF four class model: Class A (low risk), Class B (low moderate, ~EU IIa), Class C (moderate-high, EU IIb/III) and Class D (high risk, Class III/IV and active implantables). Oman accepts the classification of your country of origin jurisdiction but DGPA&DC may reclassify a device based on its own risk assessment, so classification should be confirmed before submission.

Listing (notification) is the current mandatory step every device must be entered in the Medical Device Control Department database via the MOH eServices portal before import or sale. Registration is the fuller risk based authorization being rolled out under Decree 113/2020, requiring a CSDT dossier and conformity evidence. NexorTest manages both  immediate listing for fast entry and registration to future proof your access.

The listing/notification pathway typically takes around 3-4 months once the AR is appointed and the dossier is complete. Full CSDT-based registration for higher risk Class C and D devices generally runs 4-6 months. Having a CE marking or FDA clearance and a valid ISO 13485 certificate ready, and responding promptly to deficiency notices, keeps the review on track.

Core documents include a CE certificate or FDA clearance, a Free Sale Certificate or CFG, a Declaration of Conformity, a valid ISO 13485 certificate, a CSDT dossier for Class B/C/D, the AR authorization letter and Commercial Registration, and compliant labeling and IFU. Oman is an Apostille country, so certificates need only Apostille legalization rather than full consular legalization.

Market authorizations issued in Oman are valid for 5 years from the date of issue. Renewal should begin several months before expiry and requires current CE or FDA certificates, an updated ISO 13485 certificate and details of any device or manufacturing changes. Your AR maintains the listing and registration and manages renewals to avoid any gap in market access.

Yes, NexorTest registers IVD devices and Software as a Medical Device with the Oman MOH DGPA&DC. IVDs follow the same Class A-D framework with their own IMDRF aligned rules, and we handle classification, performance evidence and labeling. For SaMD and AI/ML devices we manage software lifecycle, validation and cybersecurity documentation. Both benefit from CE or FDA reliance where available.

Ready to Enter the Omani Market?

Get a free Oman regulatory assessment from our GCC focused specialists. We’ll map your fastest, lowest risk path to MOH DGPA&DC market authorization.

Global Regulatory Services

Expand Beyond Oman with Multi-Market Access

Scroll to Top